Clinical Trial

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 2, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Trial Details
NCT Number NCT07380412
Lead Sponsor Outliers, Inc.
Collaborators: Citruslabs
Conditions ADHD, Sleep Disturbance, Brain Fog
Enrollment 90 participants
Start Date 2025-08-12
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-02